Parameter | Score |
---|---|
1. Scale | A |
2. Study Population | B |
3. Samples | B |
4. Measurand | A |
5. Pre-Analytical | C |
6. Replicate Analysis | C |
7. Steady State | B |
8. Outlier Analysis | C |
9. Normality | A |
10. Variance Homogeneity | C |
11. ANOVA | A |
12. CI | C |
13. No of Results | C |
14. Concentrations | B |
15. Total Score | C5,6,8,10,12,13 |
Comment |
Parameter | Score |
---|---|
Matrix | Plasma |
Measurand | 25-hydroxy vitamin D3 |
Unit | nmol / L |
Overall Analytical Principle Method | Immunoassay; Other |
Number of Subjects | 187 |
Number of Subjects included in BV estimation | |
Ethinicity | Caucasian |
Age Mean / Median | |
Age Min | 45.0 |
Age Max | 58.0 |
Age SD | |
Number of Males | |
Number of Females | 187 |
State of Well Being |
Non-healthy (excl pregnant)
|
Diseases | |
Study Duration Length | 5 |
Study Duration Units | Year |
Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
Interval Units | Other |
Sampling Times | Start Time:
End Time: |
Number of Samples | 4 |
Average Number of Samples Used for BV Estimation | 4.0 |
Average Number of Replicates | 1.0 |
Estimates of CVi | 19.0 |
Calculated Confidence Intervals of CVi | Lower: , Upper: |
Estimates of CVg | |
Calculated Confidence Intervals of CVg | Lower: , Upper: |
Analytical CV | |
Calculated Confidence Intervals of Analytical CV | Lower: , Upper: |
Measurand Mean | |
Measurand Min | |
Measurand Max | |
Measurand SD |